News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Moby Strategic Shift and Operational Performance Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 …
BioHarvest Sciences reported Q2 2026 revenue of $8.8 million, a 3.8% increase year-over-year, and highlighted its first CDMO agreement for a rare premium fragrance raw material, projected to generate $20-30 million in revenue during 2027-2028. The company narrowed its 2026 consolidated revenue guidance to …
BioHarvest Sciences reported Q2 2026 revenue of $8.8M, a 3.8% year-over-year increase, with a gross margin of 58% and a narrowed net loss of $3.7M. The company secured a significant CDMO fragrance contract, revised its 2026 revenue guidance to $37–$40M, and maintained its target …
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items. This …
BioHarvest Sciences Inc. reported its second quarter 2026 financial results, securing its first CDMO Manufacturing Agreement for a 20-ton commercial production program of a rare botanical fragrance. The company reported $8.8 million in Q2 revenue, up 3.8% from Q2 2025, and is transitioning its …
BioHarvest Sciences Inc. reported second-quarter adjusted EPS of -$0.17 and revenue of $8.8 million, an increase of 3.8% year-over-year. The company's shares surged 11.43% after announcing a CDMO manufacturing agreement for a rare botanical fragrance, with limited production expected by early 2027. BioHarvest also …
* BioHarvest Sciences press release [https://seekingalpha.com/filing/309934017] (BHST [https://seekingalpha.com/symbol/BHST]): Q2 GAAP EPS of -$0.17 misses by $0.05. * Revenue of $8.84M (+3.8% Y/Y) misses by $0.61M. MORE ON BIOHARVEST SCIENCES * BioHarvest Sciences Inc. (BHST) Q1 2026 Earnings Call Transcript [https://seekingalpha.com/article/4904774-bioharvest-sciences-inc-bhst-q1-2026-earnings-call-transcript] * BioHarvest outlines 2026 …
BioHarvest Sciences reported a modest increase in H1 2026 revenue to $17.344 million, with growth in both its Products and CDMO Services business units. Despite improved liquidity and a stronger balance sheet compared to the previous year, the company flagged substantial doubt about its …
This article provides financial information for BioHarvest Sciences, Inc. (FWB:8MV0) on TradingView, specifically focusing on its enterprise value to EBIT forward. The content appears to be a stub or a placeholder for detailed financial data.
BioHarvest Sciences Inc. (NASDAQ: BHST) is set to participate in the Canaccord Genuity 46th Annual Growth Conference from August 11-13, 2026, in Boston. CEO Zaki Rakib will deliver a company presentation on August 12, 2026, at 1:00 p.m. ET and will also hold one-on-one …
BioHarvest Sciences (NASDAQ: BHST) will report its Q2 2026 financial results on August 11, 2026, before market open, followed by a conference call and webcast at 8:00 AM ET. CEO Zaki Rakib will discuss the results, business operations, and the company's 2026 strategy and …
BioHarvest Sciences Inc. announced that its CEO, Zaki Rakib, will present at the Canaccord Genuity 46th Annual Growth Conference in Boston from August 11-13, 2026. Dr. Rakib will deliver a company presentation on August 12 and participate in one-on-one investor meetings. The conference brings …
BioHarvest Sciences Inc. (BHST) announced it will report its second quarter 2026 financial results before market open on Tuesday, August 11, 2026. The company will host a conference call and webcast at 8:00 AM Eastern Time to discuss the results, provide a business operations …
BioHarvest Sciences Inc. (NASDAQ: BHST) will report its second-quarter 2026 financial results on August 11, 2026, before market open, and will host a conference call and webcast at 8:00 AM Eastern Time. CEO Zaki Rakib, nearing his first 100 days in the role, plans …
Search by ticker symbol or company name and select a result to open its chart.